| Year |
Citation |
Score |
| 2024 |
Naamneh MS, Momic T, Klazas M, Grosche J, Eble JA, Marcinkiewicz C, Khazanov N, Senderowitz H, Hoffman A, Gilon C, Katzhendler J, Lazarovici P. Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals (Basel, Switzerland). 17. PMID 38794120 DOI: 10.3390/ph17050549 |
0.414 |
|
| 2023 |
Glavaš M, Gitlin-Domagalska A, Ptaszyńska N, Starego D, Freza S, Dębowski D, Helbik-Maciejewska A, Łęgowska A, Gilon C, Rolka K. Synthesis of Novel Arginine Building Blocks with Increased Lipophilicity Compatible with Solid-Phase Peptide Synthesis. Molecules (Basel, Switzerland). 28. PMID 38067510 DOI: 10.3390/molecules28237780 |
0.4 |
|
| 2020 |
Talhami A, Swed A, Hess S, Ovadia O, Greenberg S, Schumacher-Klinger A, Rosenthal D, Shalev DE, Hurevich M, Lazarovici P, Hoffman A, Gilon C. Cyclizing Painkillers: Development of Backbone-Cyclic TAPS Analogs. Frontiers in Chemistry. 8: 532577. PMID 33282822 DOI: 10.3389/fchem.2020.532577 |
0.405 |
|
| 2020 |
Gilon C, Gitlin-Domagalska A, Lahiani A, Yehoshua-Alshanski S, Shumacher-Klinger A, Gilon D, Taha M, Sekler I, Hoffman A, Lazarovici P. Novel humanin analogs confer neuroprotection and myoprotection to neuronal and myoblast cell cultures exposed to ischemia-like and doxorubicin-induced cell death insults. Peptides. 170399. PMID 32889021 DOI: 10.1016/J.Peptides.2020.170399 |
0.346 |
|
| 2019 |
Mizrahi N, Gilon C, Atre I, Ogawa S, Parhar IS, Levavi-Sivan B. Deciphering Direct and Indirect Effects of Neurokinin B and GnRH in the Brain-Pituitary Axis of Tilapia. Frontiers in Endocrinology. 10: 469. PMID 31354632 DOI: 10.3389/Fendo.2019.00469 |
0.351 |
|
| 2019 |
Dishon S, Schumacher-Klinger A, Gilon C, Hoffman A, Nussbaum G. Myristoylation Confers Oral Bioavailability and Improves the Bioactivity of c(MyD 4-4), a Cyclic Peptide Inhibitor of MyD88. Molecular Pharmaceutics. PMID 30860380 DOI: 10.1021/Acs.Molpharmaceut.8B01180 |
0.393 |
|
| 2019 |
Naoum JN, Alshanski I, Gitlin-Domagalska A, Bentolila M, Gilon C, Hurevich M. Diffusion-Enhanced Amide Bond Formation on a Solid Support Organic Process Research & Development. 23: 2733-2739. DOI: 10.1021/Acs.Oprd.9B00398 |
0.382 |
|
| 2018 |
Räder AFB, Weinmüller M, Reichart F, Schumacher-Klinger A, Merzbach S, Gilon C, Hoffman A, Kessler H. Orally active peptides - is there a magic bullet? Angewandte Chemie (International Ed. in English). PMID 30144240 DOI: 10.1002/Anie.201807298 |
0.486 |
|
| 2018 |
Schumacher-Klinger A, Fanous J, Merzbach S, Weinmueller M, Reichart F, Räder AFB, Gitlin-Domaglaska A, Gilon C, Kessler H, Hoffman A. Enhancing oral bioavailability of cyclic RGD hexa-peptides by the Lipophilic Prodrug Charge Masking approach: Redirection of peptide intestinal permeability from paracellular to transcellular pathway. Molecular Pharmaceutics. PMID 29976060 DOI: 10.1021/Acs.Molpharmaceut.8B00466 |
0.5 |
|
| 2018 |
Dishon S, Schumacher A, Fanous J, Talhami A, Kassis I, Karussis D, Gilon C, Hoffman A, Nussbaum G. Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88. Scientific Reports. 8: 9476. PMID 29930295 DOI: 10.1038/S41598-018-27773-8 |
0.467 |
|
| 2018 |
Rubin SJS, Tal-Gan Y, Gilon C, Qvit N. Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads using Backbone Cyclization and Cycloscan - How to Do It Yourself. Current Topics in Medicinal Chemistry. PMID 29773063 DOI: 10.2174/1568026618666180518094322 |
0.746 |
|
| 2018 |
Alshanski I, Bentolila M, Gitlin-Domagalska A, Zamir D, Zorsky S, Joubran S, Hurevich M, Gilon C. Enhancing the Efficiency of the Solid Phase Peptide Synthesis (SPPS) Process by High Shear Mixing Organic Process Research & Development. 22: 1318-1322. DOI: 10.1021/Acs.Oprd.8B00225 |
0.331 |
|
| 2018 |
Räder AFB, Weinmüller M, Reichart F, Schumacher-Klinger A, Merzbach S, Gilon C, Hoffman A, Kessler H. Oral aktive Peptide: Gibt es ein Patentrezept? Angewandte Chemie. 130: 14614-14640. DOI: 10.1002/Ange.201807298 |
0.461 |
|
| 2017 |
Kessler H, Weinmüller M, Rechenmacher F, Kiran Marelli U, Reichart F, Kapp TG, Räder AB, Di Leva FS, Marinelli L, Novellino E, Muñoz Félix JM, Hodivala-Dilke K, Schumacher A, Fanous J, Gilon C, et al. Overcoming the lack of oral availability of cyclic hexapeptides: Design of a new selective and orally available ligand for the integrin αvβ3. Angewandte Chemie (International Ed. in English). PMID 29072809 DOI: 10.1002/Anie.201709709 |
0.434 |
|
| 2017 |
Naoum JN, Chandra K, Shemesh D, Gerber RB, Gilon C, Hurevich M. DMAP-assisted sulfonylation as an efficient step for the methylation of primary amine motifs on solid support. Beilstein Journal of Organic Chemistry. 13: 806-816. PMID 28546838 DOI: 10.3762/Bjoc.13.81 |
0.325 |
|
| 2015 |
Marelli UK, Ovadia O, Frank AO, Chatterjee J, Gilon C, Hoffman A, Kessler H. cis-Peptide Bonds: A Key for Intestinal Permeability of Peptides? . Chemistry (Weinheim An Der Bergstrasse, Germany). 21: 15148-52. PMID 26337831 DOI: 10.1002/Chem.201501600 |
0.414 |
|
| 2015 |
Chandra K, Naoum JN, Roy TK, Gilon C, Gerber RB, Friedler A. Mechanistic studies of malonic acid-mediated in situ acylation. Biopolymers. 104: 495-505. PMID 25846609 DOI: 10.1002/Bip.22654 |
0.6 |
|
| 2015 |
Levi I, Eskira Y, Eisenstein M, Gilon C, Hoffman A, Tal-Gan Y, Fanous J, Bersudsky Y, Belmaker RH, Agam G, Almog O. Corrigendum to Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: Molecular and behavioural aspects [Eur. Neuropsychopharmacol., 23, (2013), 1806-1815] Doi: 10.1016/j.euroneuro.2013.02.004 European Neuropsychopharmacology. 25: 2185. DOI: 10.1016/J.Euroneuro.2015.09.003 |
0.608 |
|
| 2014 |
Chandra K, Roy TK, Shalev DE, Loyter A, Gilon C, Gerber RB, Friedler A. A tandem in situ peptide cyclization through trifluoroacetic acid cleavage. Angewandte Chemie (International Ed. in English). 53: 9450-5. PMID 24827640 DOI: 10.1002/Anie.201402789 |
0.676 |
|
| 2014 |
Chandra K, Roy TK, Naoum JN, Gilon C, Gerber RB, Friedler A. A highly efficient in situ N-acetylation approach for solid phase synthesis. Organic & Biomolecular Chemistry. 12: 1879-84. PMID 24526269 DOI: 10.1039/C3Ob42096E |
0.607 |
|
| 2014 |
Chandra K, Roy TK, Shalev DE, Loyter A, Gilon C, Gerber RB, Friedler A. Frontispiece: A Tandem In Situ Peptide Cyclization through Trifluoroacetic Acid Cleavage Angewandte Chemie International Edition. 53: n/a-n/a. DOI: 10.1002/Anie.201483671 |
0.681 |
|
| 2013 |
Fu J, Ling S, Liu Y, Yang J, Naveh S, Hannah M, Gilon C, Zhang Y, Holoshitz J. A small shared epitope-mimetic compound potently accelerates osteoclast-mediated bone damage in autoimmune arthritis. Journal of Immunology (Baltimore, Md. : 1950). 191: 2096-103. PMID 23885107 DOI: 10.4049/Jimmunol.1203231 |
0.323 |
|
| 2013 |
Hurevich M, Ratner-Hurevich M, Tal-Gan Y, Shalev DE, Ben-Sasson SZ, Gilon C. Backbone cyclic helix mimetic of chemokine (C-C motif) receptor 2: a rational approach for inhibiting dimerization of G protein-coupled receptors. Bioorganic & Medicinal Chemistry. 21: 3958-66. PMID 23706536 DOI: 10.1016/J.Bmc.2013.03.019 |
0.69 |
|
| 2013 |
Levi I, Eskira Y, Eisenstein M, Gilon C, Hoffman A, Talgan Y, Fanous J, Bersudsky Y, Belmaker RH, Agam G, Almog O. Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: molecular and behavioral aspects. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1806-15. PMID 23619164 DOI: 10.1016/J.Euroneuro.2013.02.004 |
0.514 |
|
| 2013 |
Moshe L, Saper G, Szekely O, Linde Y, Gilon C, Harries D, Raviv U. Modulating the structure and interactions of lipid-peptide complexes by varying membrane composition and solution conditions Soft Matter. 9: 7117-7126. DOI: 10.1039/C3Sm00105A |
0.392 |
|
| 2012 |
Beck JG, Chatterjee J, Laufer B, Kiran MU, Frank AO, Neubauer S, Ovadia O, Greenberg S, Gilon C, Hoffman A, Kessler H. Intestinal permeability of cyclic peptides: common key backbone motifs identified. Journal of the American Chemical Society. 134: 12125-33. PMID 22737969 DOI: 10.1021/Ja303200D |
0.498 |
|
| 2012 |
Hayouka Z, Levin A, Hurevich M, Shalev DE, Loyter A, Gilon C, Friedler A. A comparative study of backbone versus side chain peptide cyclization: application for HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry. 20: 3317-22. PMID 22507205 DOI: 10.1016/J.Bmc.2012.03.039 |
0.708 |
|
| 2012 |
Tal-Gan Y, Naveh S, Klein S, Moshel O, Levitzki A, Gilon C. Studying protein-peptide interactions using benzophenone units: a case study of protein kinase B/Akt and its inhibitor PTR6154. Analytical Biochemistry. 421: 750-4. PMID 22197420 DOI: 10.1016/J.Ab.2011.11.032 |
0.735 |
|
| 2012 |
Naveh S, Tal-Gan Y, Ling S, Hoffman A, Holoshitz J, Gilon C. Developing potent backbone cyclic peptides bearing the shared epitope sequence as rheumatoid arthritis drug-leads. Bioorganic & Medicinal Chemistry Letters. 22: 493-6. PMID 22113111 DOI: 10.1016/J.Bmcl.2011.10.098 |
0.716 |
|
| 2012 |
Horwitz E, Tal-Gan Y, Temper V, Shapiro M, Gilon C, Hoffman A. Chemical trapping of vancomycin: a potential strategy for preventing selection of vancomycin-resistant Enterococci. Microbial Drug Resistance (Larchmont, N.Y.). 18: 109-15. PMID 22088148 DOI: 10.1089/Mdr.2011.0057 |
0.635 |
|
| 2011 |
Tal-Gan Y, Freeman NS, Klein S, Levitzki A, Gilon C. Metabolic stability of peptidomimetics: N-methyl and aza heptapeptide analogs of a PKB/Akt inhibitor. Chemical Biology & Drug Design. 78: 887-92. PMID 21824328 DOI: 10.1111/J.1747-0285.2011.01207.X |
0.726 |
|
| 2011 |
Tal-Gan Y, Hurevich M, Klein S, Ben-Shimon A, Rosenthal D, Hazan C, Shalev DE, Niv MY, Levitzki A, Gilon C. Backbone cyclic peptide inhibitors of protein kinase B (PKB/Akt). Journal of Medicinal Chemistry. 54: 5154-64. PMID 21650457 DOI: 10.1021/Jm2003969 |
0.754 |
|
| 2011 |
Freeman NS, Tal-Gan Y, Klein S, Levitzki A, Gilon C. Microwave-assisted solid-phase aza-peptide synthesis: aza scan of a PKB/Akt inhibitor using aza-arginine and aza-proline precursors. The Journal of Organic Chemistry. 76: 3078-85. PMID 21410283 DOI: 10.1021/Jo102422X |
0.762 |
|
| 2011 |
Ovadia O, Greenberg S, Chatterjee J, Laufer B, Opperer F, Kessler H, Gilon C, Hoffman A. The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides. Molecular Pharmaceutics. 8: 479-87. PMID 21375270 DOI: 10.1021/Mp1003306 |
0.464 |
|
| 2011 |
Hoffman A, Talgan Y, Fanous J, Agam G, Eisenstein M, Levi I, Askira Y, Almog O, Gilon C. The Calbindin-D28k binding site on inositol monophosphatase may allow inhibition independent of the lithium site of action Nature Precedings. 1-1. DOI: 10.1038/Npre.2011.6323.1 |
0.522 |
|
| 2010 |
Ovadia O, Greenberg S, Laufer B, Gilon C, Hoffman A, Kessler H. Improvement of drug-like properties of peptides: the somatostatin paradigm. Expert Opinion On Drug Discovery. 5: 655-71. PMID 22823205 DOI: 10.1517/17460441.2010.493935 |
0.47 |
|
| 2010 |
Hayouka Z, Hurevich M, Levin A, Benyamini H, Iosub A, Maes M, Shalev DE, Loyter A, Gilon C, Friedler A. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein. Bioorganic & Medicinal Chemistry. 18: 8388-95. PMID 20974536 DOI: 10.1016/J.Bmc.2010.09.046 |
0.706 |
|
| 2010 |
Hurevich M, Swed A, Joubran S, Cohen S, Freeman NS, Britan-Rosich E, Briant-Longuet L, Bardy M, Devaux C, Kotler M, Hoffman A, Gilon C. Rational conversion of noncontinuous active region in proteins into a small orally bioavailable macrocyclic drug-like molecule: the HIV-1 CD4:gp120 paradigm. Bioorganic & Medicinal Chemistry. 18: 5754-61. PMID 20619663 DOI: 10.1016/J.Bmc.2010.04.053 |
0.307 |
|
| 2010 |
Tal-Gan Y, Freeman NS, Klein S, Levitzki A, Gilon C. Synthesis and structure-activity relationship studies of peptidomimetic PKB/Akt inhibitors: the significance of backbone interactions. Bioorganic & Medicinal Chemistry. 18: 2976-85. PMID 20347317 DOI: 10.1016/J.Bmc.2010.02.031 |
0.735 |
|
| 2010 |
Hurevich M, Tal-Gan Y, Klein S, Barda Y, Levitzki A, Gilon C. Novel method for the synthesis of urea backbone cyclic peptides using new Alloc-protected glycine building units. Journal of Peptide Science : An Official Publication of the European Peptide Society. 16: 178-85. PMID 20196085 DOI: 10.1002/Psc.1218 |
0.761 |
|
| 2010 |
Ovadia O, Linde Y, Haskell-Luevano C, Dirain ML, Sheynis T, Jelinek R, Gilon C, Hoffman A. The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: the melanocortin agonist paradigm. Bioorganic & Medicinal Chemistry. 18: 580-9. PMID 20056544 DOI: 10.1016/J.Bmc.2009.12.010 |
0.49 |
|
| 2010 |
MULLER D, ZELTSER I, BITAN G, GILON C. ChemInform Abstract: Building Units for N-Backbone Cyclic Peptides. Part 3. Synthesis of Protected Nα-(ω-Aminoalkyl)amino Acids and Nα-(. omega.-Carboxyalkyl)amino Acids. Cheminform. 28: no-no. DOI: 10.1002/CHIN.199720173 |
0.34 |
|
| 2009 |
Kessler H, Chatterjee J, Doedens L, Operrer F, Biron E, Hoyer D, Schmid H, Gilon C, Hruby VJ, Mierkes DF. New perspective in peptide chemistry by N-alkylation. Advances in Experimental Medicine and Biology. 611: 229-31. PMID 19400173 DOI: 10.1007/978-0-387-73657-0_106 |
0.482 |
|
| 2009 |
Qvit N, Hatzubai A, Shalev DE, Ben-Neriah Y, Gilon C. Design and synthesis of backbone cyclic phosphopeptides: the IkappaB model. Advances in Experimental Medicine and Biology. 611: 139-40. PMID 19400129 DOI: 10.1007/978-0-387-73657-0_62 |
0.3 |
|
| 2009 |
Qvit N, Hatzubai A, Shalev DE, Friedler A, Ben-Neriah Y, Gilon C. Design and synthesis of backbone cyclic phosphorylated peptides: The IkappaB model. Biopolymers. 91: 157-68. PMID 19025995 DOI: 10.1002/Bip.21098 |
0.699 |
|
| 2009 |
EWENSON A, COHEN-SUISSA R, LEVIAN-TEITELBAUM D, SELINGER Z, CHOREV M, GILON C. Synthesis of keto-methylene and dehydro-keto-methylene pseudo-dipeptides International Journal of Peptide and Protein Research. 31: 269-280. DOI: 10.1111/J.1399-3011.1988.Tb00034.X |
0.319 |
|
| 2009 |
Freeman NS, Gilon C. The use of tin(IV) chloride for mild and selective boc deprotection on TFA cleavable Rink-amide MBHA resin Synlett. 2097-2100. DOI: 10.1055/S-0029-1217547 |
0.404 |
|
| 2009 |
Freeman NS, Hurevich M, Gilon C. Synthesis of N′-substituted Ddz-protected hydrazines and their application in solid phase synthesis of aza-peptides Tetrahedron. 65: 1737-1745. DOI: 10.1016/J.Tet.2008.11.038 |
0.541 |
|
| 2008 |
Linde Y, Ovadia O, Safrai E, Xiang Z, Portillo FP, Shalev DE, Haskell-Luevano C, Hoffman A, Gilon C. Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides. Biopolymers. 90: 671-82. PMID 18655141 DOI: 10.1002/Bip.21057 |
0.504 |
|
| 2008 |
Chatterjee J, Gilon C, Hoffman A, Kessler H. N-methylation of peptides: a new perspective in medicinal chemistry. Accounts of Chemical Research. 41: 1331-42. PMID 18636716 DOI: 10.1021/Ar8000603 |
0.494 |
|
| 2008 |
Qvit N, Monderer-Rothkoff G, Ido A, Shalev DE, Amster-Choder O, Gilon C. Development of bifunctional photoactivatable benzophenone probes and their application to glycoside substrates. Biopolymers. 90: 526-36. PMID 18459171 DOI: 10.1002/Bip.21010 |
0.318 |
|
| 2008 |
Biron E, Chatterjee J, Ovadia O, Langenegger D, Brueggen J, Hoyer D, Schmid HA, Jelinek R, Gilon C, Hoffman A, Kessler H. Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. Angewandte Chemie (International Ed. in English). 47: 2595-9. PMID 18297660 DOI: 10.1002/Anie.200705797 |
0.451 |
|
| 2008 |
Qvit N, Reuveni H, Gazal S, Zundelevich A, Blum G, Niv MY, Feldstein A, Meushar S, Shalev DE, Friedler A, Gilon C. Synthesis of a novel macrocyclic library: discovery of an IGF-1R inhibitor. Journal of Combinatorial Chemistry. 10: 256-66. PMID 18271560 DOI: 10.1021/Cc700113C |
0.66 |
|
| 2008 |
Hess S, Linde Y, Ovadia O, Safrai E, Shalev DE, Swed A, Halbfinger E, Lapidot T, Winkler I, Gabinet Y, Faier A, Yarden D, Xiang Z, Portillo FP, Haskell-Luevano C, ... Gilon C, et al. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. Journal of Medicinal Chemistry. 51: 1026-34. PMID 18220330 DOI: 10.1021/Jm701093Y |
0.358 |
|
| 2008 |
Fridkin G, Gilon C. Azo cyclization: peptide cyclization via azo bridge formation: The Journal of Peptide Research 2002, 60, 104-111 Journal of Peptide Research. 61: 158-158. DOI: 10.1034/J.1399-3011.2002.02993.X |
0.479 |
|
| 2007 |
Hess S, Ovadia O, Shalev DE, Senderovich H, Qadri B, Yehezkel T, Salitra Y, Sheynis T, Jelinek R, Gilon C, Hoffman A. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability. Journal of Medicinal Chemistry. 50: 6201-11. PMID 17983214 DOI: 10.1021/Jm070836D |
0.485 |
|
| 2007 |
Chatterjee J, Ovadia O, Zahn G, Marinelli L, Hoffman A, Gilon C, Kessler H. Multiple N-methylation by a designed approach enhances receptor selectivity. Journal of Medicinal Chemistry. 50: 5878-81. PMID 17973471 DOI: 10.1021/Jm701044R |
0.366 |
|
| 2007 |
Hurevich M, Barda Y, Gilon C. Synthesis of novel urea bridged macrocyclic molecules using BTC Heterocycles. 73: 617-625. DOI: 10.3987/Com-07-S(U)40 |
0.34 |
|
| 2007 |
Qvit N, Barda Y, Gilon C, Shalev DE. A laboratory preparation of aspartame analogs using simultaneous multiple parallel synthesis methodology Journal of Chemical Education. 84: 1988-1991. DOI: 10.1021/Ed084P1988 |
0.317 |
|
| 2006 |
Fridkin G, Rahimipour S, Ben-Aroya N, Kapitkovsky A, Di-Segni S, Rosenberg M, Kustanovich I, Koch Y, Gilon C, Fridkin M. Novel cyclic azo-bridged analogs of gonadotropin-releasing hormone. Journal of Peptide Science : An Official Publication of the European Peptide Society. 12: 106-15. PMID 16059965 DOI: 10.1002/Psc.696 |
0.471 |
|
| 2005 |
Hariton-Gazal E, Rosenbluh J, Zakai N, Fridkin G, Brack-Werner R, Wolff H, Devaux C, Gilon C, Loyter A. Functional analysis of backbone cyclic peptides bearing the arm domain of the HIV-1 Rev protein: characterization of the karyophilic properties and inhibition of Rev-induced gene expression. Biochemistry. 44: 11555-66. PMID 16114892 DOI: 10.1021/Bi050752B |
0.522 |
|
| 2005 |
Fridkin G, Bonasera TA, Litman P, Gilon C. Backbone metal-cyclization: a novel approach for simultaneous peptide cyclization and radiolabeling. Application to the combinatorial synthesis of rhenium-cyclic somatostatin analogs. Nuclear Medicine and Biology. 32: 39-50. PMID 15691660 DOI: 10.1016/J.Nucmedbio.2004.08.007 |
0.485 |
|
| 2004 |
Barda Y, Cohen N, Lev V, Ben-Aroya N, Koch Y, Mishani E, Fridkin M, Gilon C. Backbone metal cyclization: novel 99mTc labeled GnRH analog as potential SPECT molecular imaging agent in cancer. Nuclear Medicine and Biology. 31: 921-33. PMID 15464394 DOI: 10.1016/J.Nucmedbio.2004.05.003 |
0.325 |
|
| 2003 |
Gazal S, Gellerman G, Gilon C. Novel Gly building units for backbone cyclization: synthesis and incorporation into model peptides. Peptides. 24: 1847-52. PMID 15127936 DOI: 10.1016/J.Peptides.2003.09.020 |
0.497 |
|
| 2003 |
Grach C, Wang Y, Barda Y, Gilon C, Pener MP. In vivo structure-activity studies on the dark-color-inducing neurohormone of locusts. The Journal of Peptide Research : Official Journal of the American Peptide Society. 62: 37-44. PMID 12787449 DOI: 10.1034/J.1399-3011.2003.00065_2.X |
0.407 |
|
| 2002 |
Baraz L, Hutoran M, Blumenzweig I, Katzenellenbogen M, Friedler A, Gilon C, Steinitz M, Kotler M. Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region. The Journal of General Virology. 83: 2225-30. PMID 12185277 DOI: 10.1099/0022-1317-83-9-2225 |
0.598 |
|
| 2002 |
Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A. Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. Biochemistry. 41: 9208-14. PMID 12119035 DOI: 10.1021/Bi0201466 |
0.443 |
|
| 2002 |
Yerushalmi Y, Bhargava K, Gilon C, Pener MP. Structure-activity relations of the dark-colour-inducing neurohormone of locusts. Insect Biochemistry and Molecular Biology. 32: 909-17. PMID 12110298 DOI: 10.1016/S0965-1748(01)00180-1 |
0.375 |
|
| 2002 |
Fridkin G, Gilon C. Azo cyclization: peptide cyclization via azo bridge formation. The Journal of Peptide Research : Official Journal of the American Peptide Society. 60: 104-11. PMID 12102723 DOI: 10.1034/J.1399-3011.2002.02993_1.X |
0.501 |
|
| 2002 |
Blumenzweig I, Baraz L, Friedler A, Danielson UH, Gilon C, Steinitz M, Kotler M. HIV-1 Vif-derived peptide inhibits drug-resistant HIV proteases. Biochemical and Biophysical Research Communications. 292: 832-40. PMID 11944889 DOI: 10.1006/Bbrc.2002.6732 |
0.645 |
|
| 2002 |
Gazal S, Gelerman G, Ziv O, Karpov O, Litman P, Bracha M, Afargan M, Gilon C. Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units. Journal of Medicinal Chemistry. 45: 1665-71. PMID 11931620 DOI: 10.1021/Jm0100281 |
0.444 |
|
| 2002 |
Hariton-Gazal E, Friedler D, Friedler A, Zakai N, Gilon C, Loyter A. Inhibition of nuclear import by backbone cyclic peptidomimetics derived from the HIV-1 MA NLS sequence. Biochimica Et Biophysica Acta. 1594: 234-42. PMID 11904219 DOI: 10.1016/S0167-4838(01)00306-5 |
0.712 |
|
| 2001 |
Gazal S, Gellerman G, Glukhov E, Gilon C. Synthesis of novel protected Nalpha(omega-thioalkyl) amino acid building units and their incorporation in backbone cyclic disulfide and thioetheric bridged peptides. The Journal of Peptide Research : Official Journal of the American Peptide Society. 58: 527-39. PMID 12005422 DOI: 10.1034/J.1399-3011.2001.00936.X |
0.452 |
|
| 2001 |
Jiang S, Gazal S, Gelerman G, Ziv O, Karpov O, Litman P, Bracha M, Afargan M, Gilon C, Goodman M. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution. Journal of Peptide Science : An Official Publication of the European Peptide Society. 7: 521-8. PMID 11695647 DOI: 10.1002/Psc.348 |
0.37 |
|
| 2001 |
Zeltser I, Ben-Aziz O, Schefler I, Bhargava K, Altstein M, Gilon C. Insect neuropeptide antagonist. Part II. Synthesis and biological activity of backbone cyclic and precyclic PBAN antagonists. The Journal of Peptide Research : Official Journal of the American Peptide Society. 58: 275-84. PMID 11606212 DOI: 10.1034/J.1399-3011.2001.00914.X |
0.522 |
|
| 2001 |
Altstein M, Ben-Aziz O, Daniel S, Zeltser I, Gilon C. Pyrokinin/PBAN radio-receptor assay: development and application for the characterization of a putative receptor from the pheromone gland of Heliothis peltigera. Peptides. 22: 1379-89. PMID 11514018 DOI: 10.1016/S0196-9781(01)00479-X |
0.326 |
|
| 2001 |
Fridkin G, Gilon C, Gilon T, Loyter A. Systematic solid-phase synthesis of linear pseudooligolysines containing multiple adjacent CH(2)NH amide bond surrogates: potential agents for gene delivery. The Journal of Peptide Research : Official Journal of the American Peptide Society. 58: 36-44. PMID 11454168 DOI: 10.1034/J.1399-3011.2001.00870.X |
0.401 |
|
| 2001 |
Afargan M, Janson ET, Gelerman G, Rosenfeld R, Ziv O, Karpov O, Wolf A, Bracha M, Shohat D, Liapakis G, Gilon C, Hoffman A, Stephensky D, Oberg K. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin. Endocrinology. 142: 477-86. PMID 11145612 DOI: 10.1210/Endo.142.1.7880 |
0.367 |
|
| 2000 |
Zeltser I, Gilon C, Ben-Aziz O, Schefler I, Altstein M. Discovery of a linear lead antagonist to the insect pheromone biosynthesis activating neuropeptide (PBAN). Peptides. 21: 1457-65. PMID 11068091 DOI: 10.1016/S0196-9781(00)00298-9 |
0.384 |
|
| 2000 |
Friedler A, Friedler D, Luedtke NW, Tor Y, Loyter A, Gilon C. Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif. The Journal of Biological Chemistry. 275: 23783-9. PMID 10764789 DOI: 10.1074/Jbc.M002200200 |
0.679 |
|
| 2000 |
Altstein M, Ben-Aziz O, Schefler I, Zeltser I, Gilon C. Advances in the application of neuropeptides in insect control Crop Protection. 19: 547-555. DOI: 10.1016/S0261-2194(00)00071-5 |
0.347 |
|
| 1999 |
Kasher R, Oren DA, Barda Y, Gilon C. Miniaturized proteins: the backbone cyclic proteinomimetic approach. Journal of Molecular Biology. 292: 421-9. PMID 10493885 DOI: 10.1006/Jmbi.1999.3053 |
0.502 |
|
| 1999 |
Falb E, Yechezkel T, Salitra Y, Gilon C. In situ generation of Fmoc-amino acid chlorides using bis-(trichloromethyl) carbonate and its utilization for difficult couplings in solid-phase peptide synthesis. The Journal of Peptide Research : Official Journal of the American Peptide Society. 53: 507-17. PMID 10424345 DOI: 10.1034/J.1399-3011.1999.00049.X |
0.448 |
|
| 1999 |
Altstein M, Ben-Aziz O, Daniel S, Schefler I, Zeltser I, Gilon C. Backbone cyclic peptide antagonists, derived from the insect pheromone biosynthesis activating neuropeptide, inhibit sex pheromone biosynthesis in moths. The Journal of Biological Chemistry. 274: 17573-9. PMID 10364192 DOI: 10.1074/Jbc.274.25.17573 |
0.471 |
|
| 1999 |
Friedler A, Zakai N, Karni O, Friedler D, Gilon C, Loyter A. Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein. Journal of Molecular Biology. 289: 431-7. PMID 10356319 DOI: 10.1006/Jmbi.1999.2785 |
0.672 |
|
| 1999 |
Friedler A, Blumenzweig I, Baraz L, Steinitz M, Kotler M, Gilon C. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors. Journal of Molecular Biology. 287: 93-101. PMID 10074409 DOI: 10.1006/Jmbi.1998.2585 |
0.655 |
|
| 1998 |
Baraz L, Friedler A, Blumenzweig I, Nussinuv O, Chen N, Steinitz M, Gilon C, Kotler M. Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production. Febs Letters. 441: 419-26. PMID 9891983 DOI: 10.1016/S0014-5793(98)01602-0 |
0.666 |
|
| 1998 |
Karni O, Friedler A, Zakai N, Gilon C, Loyter A. A peptide derived from the N-terminal region of HIV-1 Vpr promotes nuclear import in permeabilized cells: elucidation of the NLS region of the Vpr. Febs Letters. 429: 421-5. PMID 9662462 DOI: 10.1016/S0014-5793(98)00645-0 |
0.654 |
|
| 1998 |
Friedler A, Zakai N, Karni O, Broder YC, Baraz L, Kotler M, Loyter A, Gilon C. Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells. Biochemistry. 37: 5616-22. PMID 9548947 DOI: 10.1021/Bi972878H |
0.652 |
|
| 1998 |
Gilon C, Huenges M, Mathä B, Gellerman G, Hornik V, Afargan M, Amitay O, Ziv O, Feller E, Gamliel A, Shohat D, Wanger M, Arad O, Kessler H. A backbone-cyclic, receptor 5-selective somatostatin analogue: synthesis, bioactivity, and nuclear magnetic resonance conformational analysis. Journal of Medicinal Chemistry. 41: 919-29. PMID 9526566 DOI: 10.1021/Jm970633X |
0.368 |
|
| 1998 |
Kasher R, Bitan G, Halloun C, Gilon C. Synthesis of a bicyclic BPTI mimetic containing 4-thioproline replacing Cys38 Letters in Peptide Science. 5: 101-103. DOI: 10.1007/Bf02443447 |
0.594 |
|
| 1997 |
Muller D, Zeltser I, Bitan G, Gilon C. Building Units for N-Backbone Cyclic Peptides. 3. Synthesis of Protected N(alpha)-(omega-Aminoalkyl)amino Acids and N(alpha)-(omega-Carboxyalkyl)amino Acids. The Journal of Organic Chemistry. 62: 411-416. PMID 11671417 DOI: 10.1021/Jo961580E |
0.628 |
|
| 1997 |
Broder YC, Stanhill A, Zakai N, Friedler A, Gilon C, Loyter A. Translocation of NLS-BSA conjugates into nuclei of permeabilized mammalian cells can be supported by protoplast extract. An experimental system for studying plant cytosolic factors involved in nuclear import. Febs Letters. 412: 535-9. PMID 9276462 DOI: 10.1016/S0014-5793(97)00855-7 |
0.538 |
|
| 1997 |
Bitan G, Sukhotinsky I, Mashriki Y, Hanani M, Selinger Z, Gilon C. Synthesis and biological activity of novel backbone-bicyclic substance-P analogs containing lactam and disulfide bridges. The Journal of Peptide Research : Official Journal of the American Peptide Society. 49: 421-6. PMID 9211223 DOI: 10.1111/J.1399-3011.1997.Tb00894.X |
0.694 |
|
| 1997 |
Reuveni H, Gitler A, Poradosu E, Gilon C, Levitzki A. Synthesis and biological activity of semipeptoid farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry. 5: 85-92. PMID 9043660 DOI: 10.1016/S0968-0896(96)00197-6 |
0.364 |
|
| 1997 |
Bitan G, Muller D, Kasher R, Gluhov EV, Gilon C. Building units for N-backbone cyclic peptides. Part 4. Synthesis of protected Nα-functionalized alkyl amino acids by reductive alkylation of natural amino acids Journal of the Chemical Society - Perkin Transactions 1. 1501-1510. DOI: 10.1039/A608389G |
0.675 |
|
| 1997 |
Muller D, Zeltser I, Bitan G, Gilon C. Building units for N-backbone cyclic peptides. 3. Synthesis of protected N(α)-(ω-aminoalkyl)amino acids and N(α)-(ω-carboxyalkyl)amino acids Journal of Organic Chemistry. 62: 411-416. DOI: 10.1021/jo961580e |
0.593 |
|
| 1997 |
Gilon C, Zeltser I, Daniel S, Ben-Aziz O, Schefler I, Altstein M. Rationally designed neuropeptide antagonists: A novel approach for generation of environmentally friendly insecticides Invertebrate Neuroscience. 3: 245-250. DOI: 10.1007/Bf02480381 |
0.409 |
|
| 1997 |
Bitan G, Muller D, Kasher R, Gluhov EV, Gilon C. Building units for N-backbone cyclic peptides. Part 4. Synthesis of protected Nα-functionalized alkyl amino acids by reductive alkylation of natural amino acids Journal of the Chemical Society - Perkin Transactions 1. 1501-1510. |
0.351 |
|
| 1996 |
Bitan G, Zeltser I, Byk G, Halle D, Mashriki Y, Gluhov EV, Sukhotinsky I, Hanani M, Selinger Z, Gilon C. Backbone cyclization of the C-terminal part of substance P. Part 1: The important role of the sulphur in position 11. Journal of Peptide Science : An Official Publication of the European Peptide Society. 2: 261-9. PMID 9231334 DOI: 10.1002/Psc.76 |
0.748 |
|
| 1996 |
Behrens S, Mathä B, Bitan G, Gilon C, Kessler H. Structure-activity relationship of the ring portion in backbone-cyclic C-terminal hexapeptide analogs of substance P. NMR and molecular dynamics. International Journal of Peptide and Protein Research. 48: 569-79. PMID 8985790 DOI: 10.1111/J.1399-3011.1996.Tb00876.X |
0.596 |
|
| 1996 |
Byk G, Halle D, Zeltser I, Bitan G, Selinger Z, Gilon C. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P. Journal of Medicinal Chemistry. 39: 3174-8. PMID 8759639 DOI: 10.1021/Jm960154I |
0.766 |
|
| 1995 |
Bilan G, Gilon C. Building units for N-Backbone cyclic peptides. 2. Synthesis of protected N-(ω-thioalkylene) amino acids and their incorporation into dipeptide units Tetrahedron. 51: 10513-10522. DOI: 10.1016/0040-4020(95)00663-S |
0.451 |
|
| 1995 |
Bilan G, Gilon C. Building units for N-Backbone cyclic peptides. 2. Synthesis of protected N-(ω-thioalkylene) amino acids and their incorporation into dipeptide units Tetrahedron. 51: 10513-10522. DOI: 10.1016/0040-4020(95)00663-S |
0.358 |
|
| 1995 |
Bitan G, Behrens S, Mathä B, Mashriki Y, Hanani M, Kessler H, Gilon C. New backbone cyclic substance P analogs Letters in Peptide Science. 2: 121-124. DOI: 10.1007/Bf00119137 |
0.657 |
|
| 1994 |
Grdadolnik SG, Mierke DF, Byk G, Zeltser I, Gilon C, Kessler H. Comparison of the conformation of active and nonactive backbone cyclic analogs of substance P as a tool to elucidate features of the bioactive conformation: NMR and molecular dynamics in DMSO and water. Journal of Medicinal Chemistry. 37: 2145-52. PMID 7518522 DOI: 10.1021/Jm00040A005 |
0.655 |
|
| 1992 |
Ron D, Gilon C, Hanani M, Vromen A, Selinger Z, Chorev M. N-methylated analogs of Ac[Nle28,31]CCK(26-33): synthesis, activity, and receptor selectivity. Journal of Medicinal Chemistry. 35: 2806-11. PMID 1495013 DOI: 10.1021/Jm00093A013 |
0.387 |
|
| 1992 |
Rendu F, Eldor A, Grelac F, Bachelot C, Gazit A, Gilon C, Levy-Toledano S, Levitzki A. Inhibition of platelet activation by tyrosine kinase inhibitors. Biochemical Pharmacology. 44: 881-8. PMID 1382425 DOI: 10.1016/0006-2952(92)90119-4 |
0.304 |
|
| 1992 |
Byk G, Gilon C. Building units for N-backbone cyclic peptides. 1. Synthesis of protected N-(.omega.-aminoalkylene)amino acids and their incorporation into dipeptide units Journal of Organic Chemistry. 57: 5687-5692. DOI: 10.1021/Jo00047A022 |
0.455 |
|
| 1992 |
Saulitis J, Mierke DF, Byk G, Gilon C, Kessler H. Conformation of cyclic analogues of substance P: NMR and molecular dynamics in dimethyl sulfoxide Journal of the American Chemical Society. 114: 4818-4827. DOI: 10.1021/Ja00038A054 |
0.635 |
|
| 1992 |
Ewenson A, Laufer R, Frey J, Chorev M, Selinger Z, Gilon C. Synthesis and biological activity of peptide hydroxamate inhibitors of degradation of substance P analogues European Journal of Medicinal Chemistry. 27: 179-186. DOI: 10.1016/0223-5234(92)90001-H |
0.511 |
|
| 1992 |
Byk G, Gilon C. Building units for N-backbone cyclic peptides. 1. Synthesis of protected N-(ω-aminoalkylene)amino acids and their incorporation into dipeptide units Journal of Organic Chemistry. 57: 5687-5692. |
0.682 |
|
| 1992 |
Byk G, Gilon C. Building units for N-backbone cyclic peptides. 1. Synthesis of protected N-(ω-aminoalkylene)amino acids and their incorporation into dipeptide units Journal of Organic Chemistry. 57: 5687-5692. |
0.358 |
|
| 1991 |
Bilder GE, Krawiec JA, McVety K, Gazit A, Gilon C, Lyall R, Zilberstein A, Levitzki A, Perrone MH, Schreiber AB. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. The American Journal of Physiology. 260: C721-30. PMID 1850195 DOI: 10.1152/Ajpcell.1991.260.4.C721 |
0.307 |
|
| 1991 |
Gilon C, Halle D, Chorev M, Selinger Z, Byk G. Backbone cyclization: A new method for conferring conformational constraint on peptides. Biopolymers. 31: 745-50. PMID 1718473 DOI: 10.1002/Bip.360310619 |
0.736 |
|
| 1991 |
Chorev M, Roubini E, Gilon C, Selinger Z. Toward nonpeptidal substance P mimetic analogues: design, synthesis, and biological activity. Biopolymers. 31: 725-33. PMID 1718472 DOI: 10.1002/Bip.360310617 |
0.352 |
|
| 1991 |
Roubini E, Laufer R, Gilon C, Selinger Z, Roques BP, Chorev M. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity. Journal of Medicinal Chemistry. 34: 2430-8. PMID 1714957 DOI: 10.1021/Jm00112A018 |
0.457 |
|
| 1991 |
Stavropoulos G, Karagiannis K, Cordopatis P, Halle D, Gilon C, Bar-Akiva G, Selinger Z, Chorev M. Synthesis and biological activity of substance P C-terminal hexapeptide and heptapeptide analogues. International Journal of Peptide and Protein Research. 37: 180-4. PMID 1714423 DOI: 10.1111/J.1399-3011.1991.Tb00268.X |
0.366 |
|
| 1991 |
Gazit A, Osherov N, Posner I, Yaish P, Poradosu E, Gilon C, Levitzki A. Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. Journal of Medicinal Chemistry. 34: 1896-907. PMID 1676428 DOI: 10.1021/Jm00110A022 |
0.325 |
|
| 1991 |
Levitzki A, Gazit A, Osherov N, Posner I, Gilon C. Inhibition of protein-tyrosine kinases by tyrphostins. Methods in Enzymology. 201: 347-61. PMID 1658552 DOI: 10.1016/0076-6879(91)01031-V |
0.316 |
|
| 1991 |
Ewenson A, Laufer R, Chorev M, Selinger Z, Gilon C. Analogues of substance P containing an α-hydroxy, β-amino acid: synthesis and biological activity European Journal of Medicinal Chemistry. 26: 435-442. DOI: 10.1016/0223-5234(91)90104-U |
0.42 |
|
| 1990 |
Papir-Kricheli D, Gilon C, Chorev M, Selinger Z, Devor M. Neurochemical mediators of the behavioural effects of receptor-selective substance P agonists administered intrathecally in the rat. Neuropharmacology. 29: 1055-65. PMID 1708112 DOI: 10.1016/0028-3908(90)90112-5 |
0.315 |
|
| 1990 |
Wormser U, Laufer R, Chorev M, Gilon C, Selinger Z. Proteolytic resistance and biological activity of N-methylated analogs of [pGlu6] substance P6-11. Neuropeptides. 16: 41-9. PMID 1701226 DOI: 10.1016/0143-4179(90)90028-W |
0.411 |
|
| 1989 |
Gazit A, Yaish P, Gilon C, Levitzki A. Tyrphostins I: Synthesis and biological activity of protein tyrosine kinase inhibitors Journal of Medicinal Chemistry. 32: 2344-2352. PMID 2552117 DOI: 10.1021/Jm00130A020 |
0.305 |
|
| 1989 |
Levian-Teitelbaum D, Kolodny N, Chorev M, Selinger Z, Gilon C. 1H-NMR studies of receptor-selective substance P analogues reveal distinct predominant conformations in DMSO-d6. Biopolymers. 28: 51-64. PMID 2470438 DOI: 10.1002/Bip.360280108 |
0.407 |
|
| 1988 |
Yaish P, Gazit A, Gilon C, Levitzki A. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors Science. 242: 933-935. PMID 3263702 DOI: 10.1126/Science.3263702 |
0.305 |
|
| 1988 |
Hanani M, Chorev M, Gilon C, Selinger Z. The actions of receptor-selective substance P analogs on myenteric neurons: an electrophysiological investigation European Journal of Pharmacology. 153: 247-253. PMID 2460360 DOI: 10.1016/0014-2999(88)90612-7 |
0.319 |
|
| 1988 |
Silkoff P, Karmeli F, Goldin E, Ewenson A, Gilon C, Chorev M, Laufer R, Selinger Z, Rachmilewitz D. Effect of substance P on Rat gastrointestinal transit Digestive Diseases and Sciences. 33: 74-77. PMID 2448096 DOI: 10.1007/Bf01536634 |
0.374 |
|
| 1986 |
Eckart K, Schwarz H, Chorev M, Gilon C. Sequence determination of N-terminal and C-terminal blocked peptides containing N-alkylated amino acids and structure determination of these amino acid constituents by using fast-atom-bombardment/tandem mass spectrometry European Journal of Biochemistry / Febs. 157: 209-216. PMID 3709532 DOI: 10.1111/J.1432-1033.1986.Tb09658.X |
0.457 |
|
| 1986 |
Laufer R, Gilon C, Chorev M, Selinger Z. [pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype Journal of Medicinal Chemistry. 29: 1284-1288. PMID 2433445 DOI: 10.1021/Jm00157A029 |
0.335 |
|
| 1986 |
Wormser U, Laufer R, Hart Y, Chorev M, Gilon C, Selinger Z. Highly selective agonists for substance P receptor subtypes Embo Journal. 5: 2805-2808. PMID 2431898 DOI: 10.1002/J.1460-2075.1986.Tb04571.X |
0.404 |
|
| 1986 |
Chorev M, Rubini E, Hart Y, Gilon C, Wormser U, Selinger Z. Metabolically stable analogues of substance P: Persistent action of partially modified retro-inverso analogues of substance P on rat parotid and hypothalamic slices European Journal of Pharmacology. 127: 187-195. PMID 2428641 DOI: 10.1016/0014-2999(86)90363-8 |
0.426 |
|
| 1986 |
Ewenson A, Laufer R, Chorev M, Selinger Z, Gilon C. Ketomethylene pseudopeptide analogues of substance P: Synthesis and biological activity Journal of Medicinal Chemistry. 29: 295-299. PMID 2419559 DOI: 10.1002/Chin.198624295 |
0.398 |
|
| 1986 |
Rubini E, Gilon C, Selinger Z, Chorev M. Synthesis of isosteric methylene-oxy pseudodipeptide analogues as novel amide bond surrogate units Tetrahedron. 42: 6039-6045. DOI: 10.1016/S0040-4020(01)96090-9 |
0.406 |
|
| 1986 |
CHOREV M, YAION M, WORMSER U, LEVIAN-TEITELBAUM D, GILON C, SELINGER Z. ChemInform Abstract: Partially Modified retro-inverso Peptide Analogs: [pGlu6, Phe7psi(NH-CO)Phe8]Substance P (6-11), Synthesis and Biological Activity. Chemischer Informationsdienst. 17. DOI: 10.1002/Chin.198635288 |
0.51 |
|
| 1985 |
Friedman ZY, Wormser U, Rubini E, Chorev M, Gilon C, Selinger Z. Desensitization of substance P-induced K+ release in rat parotid European Journal of Pharmacology. 117: 323-328. PMID 2416578 DOI: 10.1016/0014-2999(85)90005-6 |
0.369 |
|
| 1985 |
Laufer R, Ewenson A, Gilon C, Chorev M, Selinger Z. Inhibition of substance P degradation in rat brain preparations by peptide hydroxamic acids European Journal of Biochemistry. 150: 135-140. PMID 2410267 DOI: 10.1111/J.1432-1033.1985.Tb08998.X |
0.396 |
|
| 1984 |
Laufer R, Wormser U, Selinger Z, Chorev M, Gilon C. Ion-exchange chromatographic assay of peptidases acting on the C-terminal hexapeptide sequence of substance P Journal of Chromatography A. 301: 415-424. PMID 6209295 DOI: 10.1016/S0021-9673(01)89215-3 |
0.326 |
|
| 1984 |
Wormser U, Chorev M, Gilon C, Laufer R, Friedman ZY, Selinger Z. Substance P degrading systems of rat parotid and hypothalamus Bba - General Subjects. 798: 28-36. PMID 6200141 DOI: 10.1016/0304-4165(84)90006-0 |
0.423 |
|
| 1983 |
Grushka E, Atamna I, Gilon C, Chorev M. Liquid chromatographic separation and detection of n-methylamino acids using mobile phases containing copper(II) ions Journal of Chromatography A. 281: 125-133. DOI: 10.1016/S0021-9673(01)87872-9 |
0.339 |
|
| 1983 |
Chorev M, Rubini E, Gilon C, Wormser U, Selinger Z. Synthesis of partially modified retro-inverso substance P analogues and their biological activity Journal of Medicinal Chemistry. 26: 129-135. DOI: 10.1002/Chin.198328341 |
0.349 |
|
| 1983 |
Ribeiro A, Jardetzky O, Gilon C. 1H-NMR studies on substance P hexapeptide analogs Biopolymers. 22: 247-253. DOI: 10.1002/Bip.360220134 |
0.302 |
|
| 1981 |
Deutsch J, Gilon C, Chorev M. Field desorption mass spectrometry. II. Potassium cationization field desorption mass spectrometry of some penta- and hexapeptides derived from substance P International Journal of Peptide and Protein Research. 18: 203-207. PMID 6171537 DOI: 10.1111/J.1399-3011.1981.Tb02058.X |
0.345 |
|
| 1981 |
Gilon C, Leshem R, Grushka E. Structure-resolution relationship. I. The effect of the alkylamide side-chain of aspartyl derivatives on the resolution of amino acid enantiomers Journal of Chromatography A. 203: 365-375. DOI: 10.1016/S0021-9673(00)80307-6 |
0.314 |
|
| 1979 |
Gilon C, Klausner Y, Hassner A. A novel method for the facile synthesis of depsipeptides Tetrahedron Letters. 20: 3811-3814. DOI: 10.1016/S0040-4039(01)95531-5 |
0.349 |
|
| 1975 |
Ingwall RT, Gilon C, Goodman M. Conformational analysis of peptides in oriented polyoxyethylene by infrared dichroism Journal of the American Chemical Society. 97: 4356-4362. PMID 49373 |
0.352 |
|
| 1973 |
Monahan MW, Gilon C. A rapid method for the preparation of amino acid resin esters for Merrifield solid phase peptide synthesis Biopolymers. 12: 2513-2519. PMID 4780716 |
0.352 |
|
| 1966 |
Frankel M, Ladkany D, Gilon C, Wolman Y. The preparation of alkyloxycarbonyl amino acids and their N-hydroxysuccinimide esters Tetrahedron Letters. 7: 4765-4768. DOI: 10.1016/S0040-4039(00)72940-6 |
0.327 |
|
| Show low-probability matches. |